TY - JOUR
T1 - Extensive genetics of ALS
T2 - A population-based study in Italy
AU - Chio, Adriano
AU - Calvo, Andrea
AU - Mazzini, Letizia
AU - Cantello, Roberto
AU - Mora, Gabriele
AU - Moglia, Cristina
AU - Corrado, Lucia
AU - D'Alfonso, Sandra
AU - Majounie, Elisa
AU - Renton, Alan
AU - Pisano, Fabrizio
AU - Ossola, Irene
AU - Brunetti, Maura
AU - Traynor, Bryan J.
AU - Restagno, Gabriella
PY - 2012/11/6
Y1 - 2012/11/6
N2 - Objective: To assess the frequency and clinical characteristics of patients with mutations of major amyotrophic lateral sclerosis (ALS) genes in a prospectively ascertained, population-based epidemiologic series of cases. Methods: Thestudy population includes allALScases diagnosed in Piemonte, Italy, from January2007to June 2011. Mutations of SOD1, TARDBP, ANG, FUS, OPTN, andC9ORF72have been assessed. Results: Out of the 475 patients included in the study, 51 (10.7%) carried a mutation of an ALS-related gene (C9ORF72, 32; SOD1, 10; TARDBP, 7; FUS, 1; OPTN, 1; ANG, none). A positive family history for ALS or frontotemporal dementia (FTD) was found in 46 (9.7%) patients. Thirty-one (67.4%) of the 46 familial cases and 20 (4.7%) of the 429 sporadic cases had a genetic mutation. According to logistic regression modeling, besides a positive family history for ALS or FTD, the chance to carry a genetic mutation was related to the presence of comorbid FTD (odds ratio 3.5; p = 0.001), and age at onset ≤54 years (odds ratio 1.79; p = 0.012). Conclusions: We have found that ̃11% of patients with ALS carry a genetic mutation, with C9ORF72 being the commonest genetic alteration. Comorbid FTD or a young age at onset are strong indicators of a possible genetic origin of the disease.
AB - Objective: To assess the frequency and clinical characteristics of patients with mutations of major amyotrophic lateral sclerosis (ALS) genes in a prospectively ascertained, population-based epidemiologic series of cases. Methods: Thestudy population includes allALScases diagnosed in Piemonte, Italy, from January2007to June 2011. Mutations of SOD1, TARDBP, ANG, FUS, OPTN, andC9ORF72have been assessed. Results: Out of the 475 patients included in the study, 51 (10.7%) carried a mutation of an ALS-related gene (C9ORF72, 32; SOD1, 10; TARDBP, 7; FUS, 1; OPTN, 1; ANG, none). A positive family history for ALS or frontotemporal dementia (FTD) was found in 46 (9.7%) patients. Thirty-one (67.4%) of the 46 familial cases and 20 (4.7%) of the 429 sporadic cases had a genetic mutation. According to logistic regression modeling, besides a positive family history for ALS or FTD, the chance to carry a genetic mutation was related to the presence of comorbid FTD (odds ratio 3.5; p = 0.001), and age at onset ≤54 years (odds ratio 1.79; p = 0.012). Conclusions: We have found that ̃11% of patients with ALS carry a genetic mutation, with C9ORF72 being the commonest genetic alteration. Comorbid FTD or a young age at onset are strong indicators of a possible genetic origin of the disease.
UR - http://www.scopus.com/inward/record.url?scp=84871192467&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84871192467&partnerID=8YFLogxK
U2 - 10.1212/WNL.0b013e3182735d36
DO - 10.1212/WNL.0b013e3182735d36
M3 - Article
C2 - 23100398
AN - SCOPUS:84871192467
SN - 0028-3878
VL - 79
SP - 1983
EP - 1989
JO - Neurology
JF - Neurology
IS - 19
ER -